Ascendant Dx Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 5

Employees

  • Latest Deal Type
  • M&A

Ascendant Dx General Information

Description

Developer of diagnostic technologies designed to commercialize diagnostic technologies to aid in the diagnosis and treatment of diseases of women and children. The company's technologies are tear based which captures tear fluid to detect breast cancer in an easy, inexpensive and accurate way, enabling physicians to do a proper diagnosis of patients in an enhanced way.

Contact Information

Website
www.ascendantdx.com
Formerly Known As
Ascendant Diagnostics
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1200 Stewart Place
  • Suite 135
  • Springdale, AR 72764
  • United States
+1 (479)
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Acquirer
Namida Lab
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 1200 Stewart Place
  • Suite 135
  • Springdale, AR 72764
  • United States
+1 (479)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ascendant Dx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 01-Apr-2019 Completed Generating Revenue
3. Later Stage VC 20-Dec-2016 Completed Generating Revenue
2. Early Stage VC 20-May-2014 $2M $3.7M Completed Generating Revenue
1. Angel (individual) 13-Sep-2013 $1.7M $1.7M Completed Generating Revenue
To view Ascendant Dx’s complete valuation and funding history, request access »

Ascendant Dx Patents

  • 6

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 3

    Pending

  • Expiring in next 12 mo

Ascendant Dx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200163655-A1 Method for collecting ocular secretions for biomarker diagnostics Inactive 26-Nov-2018
US-20190120860-A1 Method for detecting brain related maladies using ocular fluid Inactive 23-Oct-2017
JP-2022110148-A Compositions and methods for diagnosing and differentiating systemic juvenile idiopathic arthritis and kawasaki disease Inactive 11-Nov-2016
EP-3529596-A1 Compositions and methods for diagnosing and differentiating systemic juvenile idiopathic arthritis and kawasaki disease Pending 11-Nov-2016
EP-3529596-A4 Compositions and methods for diagnosing and differentiating systemic juvenile idiopathic arthritis and kawasaki disease Pending 11-Nov-2016 G01N33/6893
To view Ascendant Dx’s complete patent history, request access »

Ascendant Dx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ascendant Dx Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel Capital Group (Knoxville) Angel Group Minority
Arkansas Economic Development Commission Corporation Minority
Arkansas Science & Technology Authority Government Minority
Peacehealth Southwest Medical Center Employer Contribution Plan Corporation Minority
SeedStep Angels Angel Group Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Ascendant Dx FAQs

  • When was Ascendant Dx founded?

    Ascendant Dx was founded in 2010.

  • Where is Ascendant Dx headquartered?

    Ascendant Dx is headquartered in Springdale, AR.

  • What is the size of Ascendant Dx?

    Ascendant Dx has 5 total employees.

  • What industry is Ascendant Dx in?

    Ascendant Dx’s primary industry is Diagnostic Equipment.

  • Is Ascendant Dx a private or public company?

    Ascendant Dx is a Private company.

  • What is Ascendant Dx’s current revenue?

    The current revenue for Ascendant Dx is .

  • How much funding has Ascendant Dx raised over time?

    Ascendant Dx has raised $4.18M.

  • Who are Ascendant Dx’s investors?

    Angel Capital Group (Knoxville), Arkansas Economic Development Commission, Arkansas Science & Technology Authority, Peacehealth Southwest Medical Center Employer Contribution Plan, and SeedStep Angels are 5 of 6 investors who have invested in Ascendant Dx.

  • When was Ascendant Dx acquired?

    Ascendant Dx was acquired on 01-Apr-2019.

  • Who acquired Ascendant Dx?

    Ascendant Dx was acquired by Namida Lab.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »